优糖性糖尿病酸性酸症:它与糖尿病酸性酸症有什么不同?
1Department of Undergraduate Studies, The University of Texas at Houston (UTHealth) Cizik School of Nursing, 6901 Bertner Avenue Room #748, Houston, TX 77030, USA.
Critical care nursing clinics of North America
|January 31, 2025
概括
糖尿病酸症 (DKA) 和euglycemic DKA是严重的糖尿病紧急情况. 优糖性DKA,通常与SGLT-2抑制剂有关,由于正常的血糖水平,可以错过.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病酸症 (DKA) 是一种常见的糖尿病紧急情况,通常与高血糖 (>250 mg/dL) 相关,在1型糖尿病 (T1DM) 中更为频繁.
- 优糖性DKA (eDKA) 呈现出正常或轻微升高的血糖 (<200 mg/dL),并且已越来越多地被识别为使用-葡萄糖共运输体-2 (SGLT-2) 抑制剂,主要用于2型糖尿病 (T2DM).
- 在eDKA中缺乏显著的高血糖症可能导致诊断和治疗延迟.
研究的目的:
- 审查和比较DKA和euglycemic DKA的病理生理学,诱发因素,临床表现,诊断评估和治疗策略.
- 要突出eDKA在临床实践中被忽视的潜力,因为其非典型的血糖表现.
主要方法:
- 文献综述和对DKA和euglycemicDKA现有研究的综合.
- 对这两种疾病的临床特征,风险因素和管理方案进行比较分析.
主要成果:
- DKA的特征是严重的高血糖症,而 eDKA可能呈现出接近正常的葡萄糖水平,使其识别复杂化.
- SGLT-2 抑制剂是 eDKA 的一个显著的诱发因素,特别是在T2DM患者中.
- 及时识别和适当管理对于DKA和eDKA都至关重要,以防止严重的并发症.
结论:
- 优糖性DKA是一种独特的临床实体,需要提高意识,特别是在使用SGLT-2抑制剂的患者中.
- 了解表现和风险因素的差异对于及时诊断和有效管理DKA和eDKA至关重要.
- 进一步的研究可能会阐明eDKA的特定治疗细微差别,以优化患者的治疗结果.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
852
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
852
Keto–Enol Tautomerism: Mechanism
5.1K
The keto and enol forms are known as tautomers and they constantly interconvert (or tautomerize) between the two forms under acid or base catalyzed conditions. Both the reactions involve the same steps—protonation and deprotonation— although in the reverse order.
5.1K
Acute Respiratory Failure-III
153
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
153
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149


